Why has so much variation arisen in mechanisms of transcriptional repression? Perhaps customized transcription silencing mechanisms coevolved with specific developmental strategies and needs. For example, it may be important that repression by PIE-1 is rapidly reversible because germ cell precursors in the early embryo divide to generate somatic daughter cells that must become transcriptionally active quickly. Sequestration or replacement of general transcription factors may simply be an effective method for blocking or redirecting transcription, as has been observed in some organisms where specialized TAFs redirect transcription programs toward germline genes (Wright et al., 2006) . There are many ways to alter transcription globally in order to influence differentiation. Although OMA proteins and PIE-1 are not widely conserved across species, it seems likely, as Guven-Ozkan et al. point out, that similar mechanisms may be used in higher organisms to broadly regulate transcription and to forestall differentiation.
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Detwiler, M.R., Reuben, M., Li, X., Rogers, E., and Lin, R. (2001) . Dev. Cell 1, 187-199. Ghosh, D., and Seydoux, G. (2008 The development of obesity and type 2 diabetes is influenced by a complex interaction of environmental and genetic factors. It is becoming clear that obesity is characterized by chronic activation of inflammatory pathways and that this chronic inflammation is causally linked to insulin resistance and type 2 diabetes (Hotamisligil, 2006) . Although this inflammatory etiology is principally studied in peripheral organs, such as liver and adipose tissue, obesity-induced inflammatory changes and their impact on leptin and insulin action have also been reported in the central nervous system (CNS), including the hypothalamus (De Souza et al., 2005) . Insulin action in the CNS has systemic consequences, and normal functioning of the hypothalamus is paramount not just for regulation of food intake but also for broader metabolic homeostasis. Conversely, central signals can control peripheral glucose metabolism and insulin sensitivity, particularly in the liver. In the brain, the hypothalamus is a primary site of convergence and integration of multiple nutrient-related signals including central and peripheral neural signals as well as hormonal and nutritional cues. The arcuate nucleus, situated in the mediobasal hypothalamus (MBH), integrates hormonal signals (such as insulin, leptin, and ghrelin) and metabolic fuels (such as glucose and lipids) to regulate food intake and energy balance (Cone, 2005) (Figure 1 ). Impaired regulation of arcuate nucleus neurons leads not only to obesity but also to aberrant glucose homeostasis, although the mechanisms underlying this neuronal dysfunction are not yet clearly resolved.
Activation of inflammatory signaling pathways by immune signals or nutrients inhibits insulin action. This inhibitory input involves activation of inflammatory kinases such as c-Jun N-terminal kinase (JNK) and inhibitor of kappa B kinase (IKKβ). Activation of both pathways in the liver leads to systemic insulin resistance, whereas inhibition of JNK or IKK pathways protects animals against obesity-induced insulin resistance and obesity-induced expression of inflammatory cytokines (Hotamisligil, 2006) . Although inflammatory changes have been detected in the CNS of obese mice (De Souza et al., 2005) , the biological consequences and underlying mechanisms remain unclear. In this issue of Cell, Zhang et al. (2008) now offer important insights into the link between nutritional signals and activation of inflammatory and stress pathways in the hypothalamus.
In their study, Zhang and colleagues found that IKKβ is expressed principally in neurons of the MBH but is normally stressing the Brain, fattening the Body Obesity is characterized by chronic activation of inflammatory pathways in peripheral tissues. In this issue, Zhang et al. (2008) demonstrate that inflammation also occurs in the central nervous system where it disrupts activity of the hypothalamus leading to resistance to leptin that is mediated by activation of IKK and the endoplasmic reticulum stress response.
inactive. However, chronic (dietary or genetic obesity) or acute (glucose or oleic acid exposure) overnutrition results in IKKβ/NF-κB activation. Interestingly, nutrient-induced activation of IKKβ/ NF-κB in the hypothalamus is not associated with an overt increase in cytokine production in MBH neurons. Experimental activation of the IKKβ/NF-κB signaling pathway in the hypothalamus, through virus-mediated introduction of a constitutively active IKKβ CA , leads to weight gain and increased food intake in mice fed a high-fat diet, along with remarkably impaired insulin and leptin signaling in the hypothalamus. Moreover, the authors demonstrate that suppression of IKKβ/ NF-κB signaling in the MBH protects against insulin and leptin resistance, and obesity. Negative regulation of insulin and leptin receptor signaling may involve IKKβ-mediated elevation of the protein SOCS3, which is known to block both insulin and leptin action (Hotamisligil, 2006; Howard and Flier, 2006) .
How does the brain interpret the presence of metabolic overload and transmit signals that trigger an inflammation response? In peripheral tissues, the endoplasmic reticulum (ER), when under stress, interferes with insulin action and promotes weight gain and type 2 diabetes (Hotamisligil, 2006) . ER stress initiates a complex adaptive signaling network also known as the unfolded protein response (UPR) (Figure 1 ). Mounting evidence suggests that there is a link between the UPR and inflammation mediated by JNK and IKK/NF-κB (Hotamisligil, 2006) . During the UPR, PERK-mediated attenuation of translation results in a shift in the ratio of IκB to NF-κB, thereby leading to activation of NF-κB. Also during ER stress, another UPR regulator, IRE1, binds to the adaptor protein TRAF2 (tumor-necrosis factor-α receptor-associated factor 2), which in turn mediates activation of both JNK and IKK (Figure 1) . Zhang et al. (2008) now provide evidence that insulin and leptin resistance in the hypothalamus due to increased IKKβ activity might be caused by ER stress in the brain. Indeed, markedly elevated p-PERK and p-eIF2α expression was evident in the hypothalamus of mice with diet-induced obesity. Interestingly, activation of IKKβ also led to ER stress in the hypothalamus, whereas blocking IKKβ activity in obese animals suppressed obesity-induced ER stress. In the ob/ob obese mouse, ER stress in peripheral tissues can be alleviated using chemical chaperones such as PBA and TUDCA. Zhang and colleagues now demonstrate that obesityinduced ER stress in the hypothalamus due to diet could also be suppressed by administration of TUDCA, which resulted in reduced food intake and decreased body weight. Together with the effects observed in hypothalamic leptin signaling, these results demonstrate that hypothalamic ER stress and IKK activation are mediators of leptin resistance in vivo.
Notably, the authors found that ER stress is both an upstream mediator and a downstream consequence of the activation of IKKβ/NF-κB because IKKβ activation alone could elicit ER stress responses in the hypothalamus. So why does inflammatory signaling induce ER stress but not activation of widespread cytokine production in the hypothalamus during overnutrition? Growing evidence suggests that activation of IKK does not solely reflect the transcriptional effects of NF-κB but may involve NF-κB-independent effects such as inhibition of IRS-1 in adipocytes and liver cells (Hotamisligil, 2006) . IKK has also been detected in the mTOR-Raptor complex, and its activation is linked to mTOR acti- Increased exposure to macronutrients activates sensing pathways in the hypothalamus, which in turn suppress food intake and regulate hepatic glucose output. Both acute and chronic overnutrition result in the activation of IKKβ in the hypothalamus, leading to impaired insulin and leptin signaling, which, at least in part, involves the protein SOCS3. Obesity and elevated IKKβ also trigger ER stress in the hypothalamus (red arrows, text), which leads to leptin resistance in the CNS. The contribution of other potential UPR branches and other inflammatory signaling molecules such as JNK remains to be examined. ER stress could also impair CNS function by interfering with the release of neurotransmitters. Given that both nutrients and inflammatory signaling could engage the mTOR pathway, this molecule is also shown as a potential player in obesity-induced ER stress in the CNS.
vation through direct phosphorylation of the protein TSC1 (tuberous sclerosis complex 1) (Lee et al., 2007) . Interestingly, mTOR forms an important molecular link between insulin and leptin signaling (Cota et al., 2006) . In addition, constitutive activation of mTOR triggers ER stress and inhibition of insulin action through JNK-mediated serine phosphorylation of IRS1 (Ozcan et al., 2008) . Hence, it is intriguing to speculate that IKK-mediated activation of mTOR could be one of the potential mechanisms underlying IKK-induced ER stress in the hypothalamus during overnutrition. It remains to be seen whether such a mechanism also involves JNK and whether activation of these pathways collectively produces ER stress in the hypothalamus with distinct inflammatory properties.
There are two populations of neurons that reside in the arcuate nucleus of the hypothalamus: the pro-opiomelanocortin "POMC" cells, which produce "anorexigenic" (appetite-suppressing) neuropeptides, and the agouti-related protein and neuropeptide Y-producing "NPY/AGRP" cells, which produce the "orexigenic" (appetite-stimulating) neuropeptides. Both of these neuronal populations express a functional leptin receptor. Leptin activates the POMC neurons directly but blocks the activity of neurons producing NPY/AGRP. In addition, NPY/ AGRP neurons produce the inhibitory neurotransmitter that suppresses POMC neuronal activity. It has been suggested that the juxtapositioning of the arcuate nucleus next to the median eminence and the direct contact of secretory neurons in the arcuate nucleus with the circulation might render this region more sensitive to systemic mediators (glucose, lipids, and cytokines). Another possibility is that nutrient-induced hypothalamic ER stress is a regulatory event affecting neuropeptide release that alters POMC-NPY/AGRP circuits hence modulating food intake and energy balance.
The Zhang et al. study provides an intriguing link between metabolic inflammation and dysfunction of the hypothalamus through activation of IKKβ. Moreover, insulin and leptin resistance of the hypothalamus induced by IKK/ NF-κB are both mediated by ER stress. Future studies will need to investigate how hypothalamic ER stress directly results in impaired insulin and/or leptin signaling and which branches of the UPR are activated in an inflamed hypothalamus. Is IKKβ-or ER stress-induced leptin resistance limited to the CNS or does it also occur in peripheral tissues? Could ER stress-induced leptin resistance be mediated independently of IKK or through other stress/inflammatory signaling networks such as JNK? A recent in vitro study demonstrated that ER stress-induced leptin resistance is mediated through protein tyrosine phosphatase 1B (PTP1B) and can be reversed by pretreatment with the chemical chaperone PBA (Hosoi et al., 2008) . Zhang et al. show that another ER chemical chaperone, TUDCA, could rescue ER stress in the CNS and reduce body weight and food intake. Together with the reported effects of these chemical chaperones in treating insulin resistance, fatty liver disease, and type 2 diabetes, Zhang et al.'s findings raise the possibility that both leptin and insulin resistance in obesity could be simultaneously addressed by therapeutic agents that alleviate ER stress.
